Glycemic effects of simvastatin: Where do we stand?
ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
2018-06-01
|
| Col·lecció: | Brazilian Journal of Pharmaceutical Sciences |
| Matèries: | |
| Accés en línia: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100403&lng=en&tlng=en |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|